FSNUF News and Press, Fresenius SE & Co KGaA From 10/06/22

Summary This month I had 7 transactions. New forward dividend is approximately $1,080. Next month I will look into the European real estate sector, TJX, L3Harris and Microsoft. September is over and it is yet another month to quickly forget when it comes to stock ret...

Summary I've received plenty of inquiries with regards to Fresenius and its somewhat terrible performance YTD so far. Readers are asking if I'm "out" the company, or if I continue to believe that this company can turn around at any point in time. My response is usually concise...

Summary Inflation and (expected) actions by the Federal Reserve continue to dominate market movements. Markets remain very volatile following record inflation readings paired with an aggressive Fed and negative consumer sentiment. US inflation is softening in July but continues to...

The U.S. Food and Drug Administration (FDA) on Friday approved Fresenius Kabi's ( OTCPK:FSNUF ) ( OTCPK:FSNUY ) Stimufend, a biosimilar to U.S. pharmaceutical major Amgen's ( NASDAQ: AMGN ) Neulasta drug. Stimufend is a white blood cell growth factor indicated to d...

The shares of Fresenius, one of the world's largest healthcare groups, have been in a downward and then a sideways trend since 2017. Corona pandemic has been a major challenge, especially for its subsidiary Fresenius Medical Care. Despite further waves of infection, the worst of the c...

Inflation and the better than feared earnings season dominate market movements. Markets remain very volatile following record inflation readings paired with an aggressive Fed and negative consumer sentiment. Inflation is softening in July and markets have started to rally again. U...

This month I had a total of 11 transactions. I sold my positions in Power REIT and Reinsurance Group of America. I reached over €1,000 in forward dividends. In contrast to the first half a year of 2022, July was a good month when it comes to stock returns. July wa...

Fresenius SE & Co. KGaA (FSNUF) Q2 2022 Earnings Conference Call July 28, 2022 07:30 AM ET Company Participants Markus Georgi - Senior Vice President of Investor Relations Stephan Sturm - President and Chief Executive Officer Rachel Empey - Chief Financial Of...

The following slide deck was published by Fresenius SE & Co. KGaA in conjunction with their 2022 Q2 earnings call. For further details see: Fresenius SE & Co. KGaA 2022 Q2 - Results - Earnings Call Presentation

3.2% Dividend Yield, 28% payout ratio, with a 29th consecutive dividend increase in 1Q22. Global footprint, with a dominant share in Europe and an increasing share in emerging markets. Some headwinds in labor costs and supply chain sustaining longer than expected, but tailwinds in...